Helen M Sheldrake

ORCID

Publication Activity (10 Years)

Years Active: 2018-2024
Publications (10 Years): 7

Top Venues

International journal of molecular sciences

Cancers

RSC medicinal chemistry

Organic & biomolecular chemistry

University of Bradford

University of Cambridge (PHD)

This page only lists publications with an associated author ORCID identifier.

Affiliation History

University of Bradford Oct 02 2014

United Kingdom

Lecturer in Organic and Medicinal Chemistry :: Institute of Cancer Therapeutics

University of Bradford Jan 29 2007 - Oct 01 2014

United Kingdom

RCUK Academic Fellow in Medicinal Chemistry :: Institute of Cancer Therapeutics

University of Manchester Sep 30 2004 - Jan 26 2007

United Kingdom

Postdoctoral Research Associate :: Chemistry

Education History

University of Cambridge Oct 01 2001 - Sep 30 2004

United Kingdom

PHD :: University Chemical Laboratory

Publications

Asiye Busra Boz Er, Helen M Sheldrake, Mark Sutherland
Overcoming Vemurafenib Resistance in Metastatic Melanoma: Targeting Integrins to Improve Treatment Efficacy. International journal of molecular sciences 25 (14) (2024)
Asiye Busra Boz Er, Helen M Sheldrake, Mark Sutherland
Overcoming Vemurafenib Resistance in Metastatic Melanoma: Targeting Integrins to Improve Treatment Efficacy. International journal of molecular sciences 25 (14) (2024)
Asiye Busra Boz Er, Helen M Sheldrake, Mark Sutherland
Overcoming Vemurafenib Resistance in Metastatic Melanoma: Targeting Integrins to Improve Treatment Efficacy. International journal of molecular sciences 25 (14) (2024)
Adam Throup, Manar Saleh Zraikat, Andrew Gordon, Shohreh Jafarinejad Soumehsaraei, Kathrin D Haase, Laurence H Patterson, Patricia A Cooper, Katherine Hanlon, Paul M Loadman, Mark Sutherland, Steven D Shnyder, Helen M Sheldrake
Sidechain structure-activity relationships of cyclobutane-based small molecule αvβ3 antagonists. RSC medicinal chemistry (2024)
Mark Sutherland, Andrew Gordon, Fatemah O F O Alshammari, Adam Throup, Amy Cilia La Corte, Helen Philippou, Steven D Shnyder, Laurence H Patterson, Helen M Sheldrake
Synthesis and Biological Evaluation of Cyclobutane-Based β3 Integrin Antagonists: A Novel Approach to Targeting Integrins for Cancer Therapy. Cancers 15 (16) (2023)
Ana R N Santos, Helen M Sheldrake, Ali I M Ibrahim, Chhanda Charan Danta, Davide Bonanni, Martina Daga, Simonetta Oliaro-Bosso, Donatella Boschi, Marco Lucio Lolli, Klaus Pors
Exploration of [2 + 2 + 2] cyclotrimerisation methodology to prepare tetrahydroisoquinoline-based compounds with potential aldo-keto reductase 1C3 target affinity. MedChemComm 10 (8) (2019)
Adam Throup, Laurence H Patterson, Helen M Sheldrake
Intramolecular thermal stepwise [2 + 2] cycloadditions: investigation of a stereoselective synthesis of [n.2.0]-bicyclolactones. Organic & biomolecular chemistry 14 (40) (2018)

Helen M Sheldrake.css-eqlu8i{font-size:small;padding-left:4px;}

Publication Activity (10 Years)

Top Topics

Top Venues

Helen M Sheldrake